Gjyrezi, A., Xie, F., Voznesensky, O., Khanna, P., Calagua, C., Bai, Y., . . . Bhatt, R. S. (2020). Taxane resistance in prostate cancer is mediated by decreased drug-target engagement. J Clin Invest.
Chicago Style aipamenaGjyrezi, Ada, et al. "Taxane Resistance in Prostate Cancer Is Mediated By Decreased Drug-target Engagement." J Clin Invest 2020.
MLA aipamenaGjyrezi, Ada, et al. "Taxane Resistance in Prostate Cancer Is Mediated By Decreased Drug-target Engagement." J Clin Invest 2020.
Kontuz: berrikusi erreferentzia hauek erabili aurretik.